BRPI0206841B8 - aplicação de depsipeptídeo cíclico - Google Patents

aplicação de depsipeptídeo cíclico

Info

Publication number
BRPI0206841B8
BRPI0206841B8 BRPI0206841A BRPI0206841B8 BR PI0206841 B8 BRPI0206841 B8 BR PI0206841B8 BR PI0206841 A BRPI0206841 A BR PI0206841A BR PI0206841 B8 BRPI0206841 B8 BR PI0206841B8
Authority
BR
Brazil
Prior art keywords
application
cyclic depsipeptide
crystal modification
depsipeptide
cyclic
Prior art date
Application number
Other languages
English (en)
Inventor
Harder Achim
Von Samson-Himmelstjerna Georg
Kalbe Jochen
Traeubel Michael
Original Assignee
Bayer Animal Health Gmbh
Bayer Ip Gmbh
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh, Bayer Ip Gmbh, Bayer Ag filed Critical Bayer Animal Health Gmbh
Publication of BR0206841A publication Critical patent/BR0206841A/pt
Publication of BRPI0206841B1 publication Critical patent/BRPI0206841B1/pt
Publication of BRPI0206841B8 publication Critical patent/BRPI0206841B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

"modificação cristalina de um depsipeptídeo cíclico com melhor eficácia". a invenção refere-se à aplicação da modificação cristalina (i) do depsipeptídeo cíclico da fórmula (i) para a preparação de medicamentos, especialmente para o combate de endoparasitas.
BR0206841-9 2001-02-01 2002-01-21 aplicação de depsipeptídeo cíclico BRPI0206841B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10104362.7 2001-02-01
DE10104362A DE10104362A1 (de) 2001-02-01 2001-02-01 Kristallmodifikation eines cyclischen Depsipeptids mit besserer Wirksamkeit
PCT/EP2002/000541 WO2002066048A1 (de) 2001-02-01 2002-01-21 Kristallmodifikation eines cyclischen depsipeptids mit besserer wirksamkeit

Publications (3)

Publication Number Publication Date
BR0206841A BR0206841A (pt) 2004-02-25
BRPI0206841B1 BRPI0206841B1 (pt) 2018-02-14
BRPI0206841B8 true BRPI0206841B8 (pt) 2021-05-25

Family

ID=7672376

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0206841-9 BRPI0206841B8 (pt) 2001-02-01 2002-01-21 aplicação de depsipeptídeo cíclico

Country Status (28)

Country Link
US (1) US20040115483A1 (pt)
EP (1) EP1357932B1 (pt)
JP (1) JP2004525111A (pt)
KR (2) KR20030081378A (pt)
CN (1) CN1278735C (pt)
AT (1) ATE284703T1 (pt)
AU (1) AU2002226415B2 (pt)
BR (1) BRPI0206841B8 (pt)
CA (1) CA2436832C (pt)
CR (1) CR7039A (pt)
CZ (1) CZ299564B6 (pt)
DE (2) DE10104362A1 (pt)
EE (1) EE05490B1 (pt)
ES (1) ES2233805T3 (pt)
HK (1) HK1075013A1 (pt)
HR (1) HRP20030635A2 (pt)
HU (1) HU229229B1 (pt)
IL (2) IL157026A0 (pt)
MX (1) MXPA03006866A (pt)
NO (1) NO331289B1 (pt)
NZ (1) NZ527230A (pt)
PL (1) PL213106B1 (pt)
PT (1) PT1357932E (pt)
RU (1) RU2300390C2 (pt)
SK (1) SK286280B6 (pt)
UA (1) UA74623C2 (pt)
WO (1) WO2002066048A1 (pt)
ZA (1) ZA200305864B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080003546A1 (en) * 2006-06-29 2008-01-03 Dunbar Kimberly L Animated digital charted yarncraft instruction
DK3298027T3 (da) 2015-05-20 2021-08-09 Boehringer Ingelheim Animal Health Usa Inc Anthelmintiske depsipeptidforbindelser
US10344056B2 (en) 2015-12-28 2019-07-09 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
BR112019009977A2 (pt) 2016-11-16 2019-08-27 Boehringer Ingelheim Animal Health Usa Inc compostos depsipeptídicos anti-helmínticos
CN114262303A (zh) * 2022-01-04 2022-04-01 丽珠集团福州福兴医药有限公司 一种艾默德斯的单晶型ii及其制备方法
CN114195732A (zh) * 2022-01-04 2022-03-18 丽珠集团福州福兴医药有限公司 一种艾默德斯的单晶型iii及其制备方法
CN114989110A (zh) * 2022-07-13 2022-09-02 丽珠集团福州福兴医药有限公司 单晶型ⅳ的艾默德斯及其制备方法
CN115010680A (zh) * 2022-07-13 2022-09-06 丽珠集团福州福兴医药有限公司 单晶型i的艾默德斯及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2096907A (en) * 1981-04-22 1982-10-27 Exxon Research Engineering Co Distillation column with steam stripping
EP0634408B1 (en) * 1992-03-17 2002-01-02 Fujisawa Pharmaceutical Co., Ltd. Depsipeptide derivative, production thereof and use thereof
DE4317458A1 (de) * 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
CN1071323C (zh) * 1995-06-30 2001-09-19 藤泽药品工业株式会社 缩肽衍生物或其盐的制造方法
BR9610527A (pt) * 1995-09-22 1999-12-21 Meiji Sheika Kaisha Ltd Novos derivados de substâncias de ciclodepsipeptìdeo pf1022
NZ504812A (en) * 1997-11-10 2002-08-28 Fujisawa Pharmaceutical Co A crystal of a phenyl-morpholino substituted depsipeptide derivative
DE10008128A1 (de) * 2000-02-22 2001-08-23 Bayer Ag Endoparasitizide Mittel
DE10031044A1 (de) * 2000-06-26 2002-01-03 Bayer Ag Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere

Also Published As

Publication number Publication date
EP1357932B1 (de) 2004-12-15
PL213106B1 (pl) 2013-01-31
RU2003126589A (ru) 2005-02-27
HUP0302880A3 (en) 2005-05-30
ATE284703T1 (de) 2005-01-15
CN1592631A (zh) 2005-03-09
WO2002066048A1 (de) 2002-08-29
BRPI0206841B1 (pt) 2018-02-14
ZA200305864B (en) 2004-08-27
AU2002226415B2 (en) 2007-03-22
CZ20032063A3 (cs) 2003-11-12
US20040115483A1 (en) 2004-06-17
CA2436832A1 (en) 2002-08-29
MXPA03006866A (es) 2004-05-31
PT1357932E (pt) 2005-04-29
CZ299564B6 (cs) 2008-09-03
NO20033413L (no) 2003-09-26
CA2436832C (en) 2013-06-11
DE50201777D1 (de) 2005-01-20
SK9882003A3 (en) 2003-12-02
SK286280B6 (sk) 2008-06-06
HK1075013A1 (en) 2005-12-02
HRP20030635A2 (en) 2005-10-31
PL362389A1 (en) 2004-11-02
IL157026A0 (en) 2004-02-08
KR20030081378A (ko) 2003-10-17
EP1357932A1 (de) 2003-11-05
HUP0302880A2 (hu) 2003-12-29
WO2002066048A8 (de) 2003-11-20
DE10104362A1 (de) 2002-08-08
KR20090041451A (ko) 2009-04-28
IL157026A (en) 2010-11-30
RU2300390C2 (ru) 2007-06-10
HU229229B1 (en) 2013-09-30
CN1278735C (zh) 2006-10-11
ES2233805T3 (es) 2005-06-16
NO331289B1 (no) 2011-11-21
EE200300365A (et) 2003-10-15
CR7039A (es) 2004-06-08
NZ527230A (en) 2005-04-29
BR0206841A (pt) 2004-02-25
EE05490B1 (et) 2011-12-15
UA74623C2 (en) 2006-01-16
JP2004525111A (ja) 2004-08-19
NO20033413D0 (no) 2003-07-30

Similar Documents

Publication Publication Date Title
BR0212386A (pt) Composto, formulação farmacêutica, e, uso de um composto
BR0207583A (pt) Derivados de poliamida possuindo atividade antibacteriana, antifungo ou antitumor
BR0112030A (pt) Novos compostos que possuem atividade antibacteriana, antifúngica ou antitumor
BR0114410A (pt) Associação de um antagonista de receptor cb1 e de sibutramina, as composições farmacêuticas que os contêm e a respectiva utilização para o tratamento da obesidade
BR9713147A (pt) Benzamidoaldeìdo, uso do mesmo, benzamida, e, preparação medicamentosa para administração oral, parenteral ou intraperitoneal.
CY1113003T1 (el) Ευσταθη παρασκευασματα laquinimod
BRPI0417717A (pt) composto, composição farmacêutica, e, uso de um composto
BR0213358A (pt) Uso de flibanserina
SE0201544D0 (sv) Novel compounds and thier use
DE60034240D1 (de) Drogen zur behandlung maligner tumoren
BR0210028A (pt) Agentes antibacterianos
NO20033918D0 (no) Ny anvendelse av peptidklasse av forbindelser for behandling av allodyni eller andre typer av kronisk smerte eller fantomsmerte
BR0209127A (pt) compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
DE60205870D1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
CY1107939T1 (el) Συνεργικοι φαρμακευτικοι συνδυασμοι για την προληψη ή την αγωγη του διαβητη
BR0211972A (pt) Composição oftálmica
BR0113590A (pt) 7-oxo-piridopirimidinas
EA200600971A1 (ru) Применение замещённых 2 - аминотетралинов для профилактического лечения болезни паркинсона
BR0206697A (pt) Fio tingido espacialmente
BR0212353A (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0206841B8 (pt) aplicação de depsipeptídeo cíclico
BRPI0406824A (pt) Indolonaoxazoldinonas antiibacterianas, intermediários para seu preparo e composições farmacêuticas que as contêm
BRPI0415123A (pt) uso de l-butilftalida e respectiva composição farmacêutica
TW200507838A (en) Active substance combination comprising a 2,5-dihydroxybenzenesulfonic compound and a potassium ion channel modulator
BR0114395A (pt) Composição farmacêutica para administração por suprimento via oral

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: BAYER ANIMAL HEALTH GMBH (DE)

Free format text: TRANSFERIDO DE: BAYER AKTIENGESELLSCHAFT

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: BAYER INTELLECTUAL PROPERTY GMBH (DE)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 21/01/2002 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 21/01/2022